BIO
Financials
- Market Capitalization 7.96 B
- Employee 7 450
- Founded N/A
- CEO Norman David Schwartz
- Website www.bio-rad.com
- Headquarter Delaware, United States
- FIGI BBG000DY28W5
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 974 |  GKOS Glaukos Corporation Common Stock | 152.87 USD | +0.07% | +2.60% | +19.39% | +46.12% | 8.98 B USD | ||
| 976 |  BRKR Bruker Corporation - Common Stock | 58.97 USD | -1.81% | -3.74% | +7.69% | +35.19% | 8.98 B USD | ||
| 1401 |  LIVN LivaNova PLC - Ordinary Shares | 82.98 USD | +0.51% | -2.08% | +4.17% | +50.33% | 4.56 B USD | ||
| 1524 |  IRTC iRhythm Holdings, Inc. - Common Stock | 118.68 USD | +2.20% | -7.22% | +5.69% | -34.15% | 3.90 B USD |
Frequently asked questions about Bio-Rad Laboratories, Inc. Class A Common Stock
What is the Bio-Rad Laboratories, Inc. Class A Common Stock stock price today?
The current price of Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) is 297.56. Over the past 24 hours, the stock has changed by +0.48%. Follow the BIO chart for real-time price dynamics.
What is the stock ticker of Bio-Rad Laboratories, Inc. Class A Common Stock?
Bio-Rad Laboratories, Inc. Class A Common Stock trades under the ticker BIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bio-Rad Laboratories, Inc. Class A Common Stock stock going up?
BIO has changed by -0.36% over the last week, +1.29% over the last month, and -11.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Bio-Rad Laboratories, Inc. Class A Common Stock net income for the last quarter?
Bio-Rad Laboratories, Inc. Class A Common Stock reported net income of -527.1 M for the last quarter. The previous quarter showed 720 M, which means net income changed by -173.21%.
How many employees does Bio-Rad Laboratories, Inc. Class A Common Stock have?
As of the latest available data, Bio-Rad Laboratories, Inc. Class A Common Stock has 7 450 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA?
Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA is 34.1 M, and its EBITDA margin is 5.76%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bio-Rad Laboratories, Inc. Class A Common Stock stock?
You can buy Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bio-Rad Laboratories, Inc. Class A Common Stock stock?
Investing in Bio-Rad Laboratories, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIO chart and related analysis on metatrader.com as part of your research.